Report Highlights
Including: 1) By Drug Class: Mood Stabilizers; Antipsychotic Drugs; Antidepressant Drugs
2) By Mechanism: Selective Serotonin Reuptake Inhibitors; Serotonin-norepinephrine Reuptake Inhibitors; Tricyclic Antidepressants; Monoamine Oxidase Inhibitors; Benzodiazepines; Beta-Blockers
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
Covering: AbbVie Inc.; Pfizer Inc.; Astellas Pharma Inc.; AstraZeneca PLC; Bristol-Myers Squibb
Bipolar Disorder Therapeutics Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global bipolar disorder therapeutics market.
This report focuses on bipolar disorder therapeutics market which is experiencing strong growth. The report gives a guide to the bipolar disorder therapeutics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the bipolar disorder therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Bipolar Disorder Therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider bipolar disorder therapeutics market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The bipolar disorder therapeutics market section of the report gives context. It compares the bipolar disorder therapeutics market with other segments of the bipolar disorder therapeutics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, bipolar disorder therapeutics indicators comparison.
Scope
Markets Covered:
- By Drug Class: Mood Stabilizers; Antipsychotic Drugs; Antidepressant Drugs; Other Drugs
- By Mechanism: Selective Serotonin Reuptake Inhibitors; Serotonin-norepinephrine Reuptake Inhibitors; Tricyclic Antidepressants; Monoamine Oxidase Inhibitors; Benzodiazepines; Beta-Blockers; Other Mechanisms
- By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: AbbVie Inc.; Allergan; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Global Historic Market Growth, 2016-2021, $ Billion
- Table 2 : Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
- Table 3 : Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 4 : Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 5 : Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 6 : Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 7 : Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 8 : Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 9 : Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 10 : China, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 11 : China, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 12 : India, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 13 : India, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 14 : Japan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 15 : Japan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 16 : Australia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 17 : Australia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 18 : Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 19 : Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 20 : South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 21 : South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 22 : Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 23 : Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 24 : UK, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 25 : UK, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 26 : Germany, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 27 : Germany, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 28 : France, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 29 : France, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 30 : Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 31 : Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 32 : Russia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 33 : Russia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 34 : North America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 35 : North America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 36 : USA, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 37 : USA, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 38 : South America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 39 : South America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 40 : Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 41 : Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 42 : Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 43 : Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 44 : Africa, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 45 : Africa, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 46 : AbbVie Inc. Financial Performance
- Table 47 : Pfizer Inc. Financial Performance
- Table 48 : Astellas Pharma Inc Financial Performance
- Table 49 : AstraZeneca PLC Financial Performance
- Table 50 : Bristol-Myers Squibb Financial Performance
- Figure 1 : Global Historic Market Growth, 2016-2021, $ Billion
- Figure 2 : Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
- Figure 3 : Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 4 : Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 5 : Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 6 : Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 7 : Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 8 : Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 9 : Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 10 : China, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 11 : China, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 12 : India, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 13 : India, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 14 : Japan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 15 : Japan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 16 : Australia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 17 : Australia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 18 : Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 19 : Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 20 : South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 21 : South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 22 : Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 23 : Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 24 : UK, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 25 : UK, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 26 : Germany, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 27 : Germany, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 28 : France, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 29 : France, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 30 : Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 31 : Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 32 : Russia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 33 : Russia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 34 : North America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 35 : North America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 36 : USA, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 37 : USA, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 38 : South America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 39 : South America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 40 : Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 41 : Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 42 : Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 43 : Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 44 : Africa, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 45 : Africa, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 46 : AbbVie Inc. Financial Performance
- Figure 47 : Pfizer Inc. Financial Performance
- Figure 48 : Astellas Pharma Inc Financial Performance
- Figure 49 : AstraZeneca PLC Financial Performance
- Figure 50 : Bristol-Myers Squibb Financial Performance
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More